成人における脂肪組織インスリン抵抗性およびアディポカインと肝臓の脂肪蓄積との関連 ―横断研究

Saved in:
Bibliographic Details
Published in健康支援 Vol. 27; no. 1; pp. 1 - 9
Main Authors 引地, 優人, 内田, 遼太, 中垣内, 真樹, 沼尾, 成晴, 藤田, 英二
Format Journal Article
LanguageJapanese
Published 日本健康支援学会 2025
Subjects
Online AccessGet full text
ISSN1345-0174
2758-3449
DOI10.57438/jshp.20240724_1

Cover

Author 藤田, 英二
中垣内, 真樹
内田, 遼太
沼尾, 成晴
引地, 優人
Author_xml – sequence: 1
  fullname: 引地, 優人
  organization: 鹿屋体育大学大学院体育学研究科体育学専攻
– sequence: 1
  fullname: 内田, 遼太
  organization: 鹿屋体育大学スポーツイノベーション推進機構ヘルスプロモーション部門
– sequence: 1
  fullname: 中垣内, 真樹
  organization: 鹿屋体育大学スポーツ生命科学系
– sequence: 1
  fullname: 沼尾, 成晴
  organization: 鹿屋体育大学スポーツ生命科学系
– sequence: 1
  fullname: 藤田, 英二
  organization: 鹿屋体育大学スポーツ生命科学系
BookMark eNpFUE1LAlEAfIRBVt479gfW3te-tx5D7AOCLnVe3q676WIlrpdu7lNQjKCo7CSEBvlBXcKgfk4vdtd_kZLUZWaYGeYwqyBxdn7mALCBYFrnlBhbnl8opzHEFHJMTbQEkpjrhkYozSRAEhGqaxBxugJSvl-0IGScIYRYErTC1vX356cKxipoq-BGycu4IWM5iiaN6ONOySdVf1PyQ9VHMxG2J2H7Iaw9z8uypYJZ1FP1ppJ9Ve8qOV70g0Esu3HzVgWvv2vxbSMaXs38mTPt9Ka1_uZX7T4cjMLOS_R4Fw3f18GyK0q-k1rwGjjeyR1l97SDw9397PaB5mHCMhriyDZsSAxh5ZHu4AzjyNVhxhAUUwQtl1GS57ahI-EagmGqE8QJ4ToRzGIoT9ZA7nfX86vixDHLleKpqFyYolIt2iXHnD9pYm6iOfw_-pfbBVExPUF-ACPwnu0
ContentType Journal Article
Copyright 2025 日本健康支援学会
Copyright_xml – notice: 2025 日本健康支援学会
DOI 10.57438/jshp.20240724_1
DeliveryMethod fulltext_linktorsrc
EISSN 2758-3449
EndPage 9
ExternalDocumentID article_jshp_27_1_27_20240724_1_article_char_ja
GrantInformation 宮崎県児湯郡木城町/鹿屋体育大学受託研究
鹿屋体育大学令和5年度重点プロジェクト事業
GroupedDBID ABJNI
ALMA_UNASSIGNED_HOLDINGS
JSF
RJT
ID FETCH-LOGICAL-j2369-171c8c038abd15e29671f5098a42410bf643d7c851af8a624531733753a6b61d3
ISSN 1345-0174
IngestDate Wed Sep 03 06:30:59 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 1
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2369-171c8c038abd15e29671f5098a42410bf643d7c851af8a624531733753a6b61d3
OpenAccessLink https://www.jstage.jst.go.jp/article/jshp/27/1/27_20240724_1/_article/-char/ja
PageCount 9
ParticipantIDs jstage_primary_article_jshp_27_1_27_20240724_1_article_char_ja
PublicationCentury 2000
PublicationDate 2025
PublicationDateYYYYMMDD 2025-01-01
PublicationDate_xml – year: 2025
  text: 2025
PublicationDecade 2020
PublicationTitle 健康支援
PublicationYear 2025
Publisher 日本健康支援学会
Publisher_xml – name: 日本健康支援学会
References 13) Adams-Huet B, Devaraj S, Siegel D, Siegel D, Jialal I.: Increased adipose tissue insulin resistance in metabolic syndrome: relationship to circulating adipokines. Metab Syndr Relat Disord, 2014; 12:503-507. DOI: 10.1089/met.2014.0092
6) Saladin R, De Vos P, Guerre-Millo M, et al.: Transient increase in obese gene expression after food intake or insulin administration. Nature, 1995; 377:527-529. DOI: 10.1038/377527a0
23) Kim JY, Bacha F, Tfayli H, Michaliszyn SF, Yousuf S, Arslanian S.: Adipose tissue insulin resistance in youth on the spectrum from normal weight to obese and from normal glucose tolerance to impaired glucose tolerance to type 2 diabetes. Diabetes Care, 2019; 42:265-272. DOI: 10.2337/dc18-1178
3) Delarue J, Magnan C.: Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care, 2007; 10:142-148. DOI: 10.1097/MCO.0b013e328042ba90
1) Feng G, Valenti L, Wong VW, et al.: Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol, 2024; 21:46-56. DOI: 10.1038/s41575-023-00846-4
7) Pajvani UB, Du X, Combs TP, et al.: Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem, 2003; 278: 9073-9085. DOI: 10.1074/jbc.M207198200
8) Mohlig M, Wegewitz U, Osterhoff M, et al.: Insulin decreases human adiponectin plasma levels. Horm Metab Res, 2002; 34:655-658. DOI: 10.1055/s-2002-38248
16) Lee JJ, Britton KA, Pedley A, et al.: Adipose tissue depots and their cross-sectional associations with circulating biomarkers of metabolic regulation. Journal of the American Heart Association, 2016: 5. DOI: 10.1161/JAHA.115.002936
2) Yki-Jarvinen H.: Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. The lancet Diabetes & endocrinology, 2014; 2:901-910. DOI: 10.1016/S2213-8587(14)70032-4
10) Hosooka T, Hosokawa Y, Matsugi K, et al.: The PDK1-FoxO1 signaling in adipocytes controls systemic insulin sensitivity through the 5-lipoxygenase-leukotriene B(4) axis. Proc Natl Acad Sci U S A, 2020; 117:11674-11684. DOI: 10.1073/pnas.1921015117
15) Fischer J, Volzke H, Kassubek J, et al.: Associations of a panel of adipokines with fat deposits and metabolic phenotypes in a general population. Obesity, 2020; 28:1550-1559. DOI: 10.1002/oby.22871
18) Sondergaard E, Espinosa De Ycaza AE, Morgan-Bathke M, et al.: How to measure adipose tissue insulin sensitivity. J Clin Endocrinol Metab, 2017; 102:1193-1199. DOI: 10.1210/jc.2017-00047
20) Bosquet A, Guaita-Esteruelas S, et al.: Exogenous FABP4 induces endoplasmic reticulum stress in HepG2 liver cells. Atherosclerosis, 2016; 249:191-199. DOI: 10.1016/j.atherosclerosis.2016.04.012
5) Gastaldelli A, Harrison SA, Belfort-Aguilar R, et al.: Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology, 2009; 50:1087-1093. DOI: 10.1002/hep.23116
17) Tanaka M, Takahashi S, Higashiura Y, et al.: Circulating level of fatty acid-binding protein 4 is an independent predictor of metabolic dysfunction-associated fatty liver disease in middle-aged and elderly individuals. Journal of diabetes investigation, 2021; 13: 878-888. DOI: 10.1111/jdi.13735
12) Zhang K, Pan H, Wang L, Yang H, Zhu H, Gong F.: Adipose tissue insulin resistance is closely associated with metabolic syndrome in northern Chinese populations. Diabetes Metab Syndr Obes, 2021; 14:1117-1128. DOI: 10.2147/DMSO.S291350
21) Francisco V, Sanz MJ, Real JT, et al.: Adipokines in non-alcoholic fatty liver disease: Are we on the road toward new biomarkers and therapeutic targets? Biology(Basel), 2022: 11. DOI: 10.3390/biology11081237
11) Semnani-Azad Z, Connelly PW, Bazinet RP, et al.: Adipose tissue insulin resistance is longitudinally associated with adipose tissue dysfunction, circulating lipids, and dysglycemia: The PROMISE Cohort. Diabetes Care, 2021; 44:1682-1691. DOI: 10.2337/dc20-1918
4) Xu Y, Ma X, Pan X, He X, Wang Y, Bao Y.: Serum adipocyte fatty acid-binding protein levels: An indicator of non-alcoholic fatty liver disease in Chinese individuals. Liver Int, 2019; 39: 568-574. DOI: 10.1111/liv.14021
19) Bedogni G, Bellentani S, Miglioli L, Morgan-Bathke M, Jensen MD.: The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol, 2006; 6:33. DOI: 10.1186/1471-230X-6-33
24) Wei Y, Liu J, Wang G, Wang Y.: Sex differences in the association between adipose insulin resistance and non-alcoholic fatty liver disease in Chinese adults. Biol Sex Differ, 2023; 14:69. DOI: 10.1186/s13293-023-00549-0
9) Mita T, Furuhashi M, Hiramitsu S, et al.: FABP4 is secreted from adipocytes by adenyl cyclase-PKA-and guanylyl cyclase-PKG-dependent lipolytic mechanisms. Obesity, 2015; 23:359-367. DOI: 10.1002/oby.20954
22) Hershkop K, Besor O, Santoro N, Pierpont B, Caprio S, Weiss R.: Adipose insulin resistance in obese adolescents across the spectrum of glucose tolerance. J Clin Endocrinol Metab, 2016; 101:2423-2431. DOI: 10.1210/jc.2016-1376
14) Chiriaco M, Nesti L, Flyvbjerg A, et al.: At any level of adiposity, relatively elevated leptin concentrations are associated with decreased insulin sensitivity. J Clin Endocrinol Metab, 2024; 109:461-470. DOI: 10.1210/clinem/dgad505
25) Li X, Liu J, Zhou B, et al.: Sex differences in the effect of testosterone on adipose tissue insulin resistance from overweight to obese adults. J Clin Endocrinol Metab, 2021; 106:2252-2263. DOI: 10.1210/clinem/dgab325
References_xml – reference: 9) Mita T, Furuhashi M, Hiramitsu S, et al.: FABP4 is secreted from adipocytes by adenyl cyclase-PKA-and guanylyl cyclase-PKG-dependent lipolytic mechanisms. Obesity, 2015; 23:359-367. DOI: 10.1002/oby.20954
– reference: 23) Kim JY, Bacha F, Tfayli H, Michaliszyn SF, Yousuf S, Arslanian S.: Adipose tissue insulin resistance in youth on the spectrum from normal weight to obese and from normal glucose tolerance to impaired glucose tolerance to type 2 diabetes. Diabetes Care, 2019; 42:265-272. DOI: 10.2337/dc18-1178
– reference: 8) Mohlig M, Wegewitz U, Osterhoff M, et al.: Insulin decreases human adiponectin plasma levels. Horm Metab Res, 2002; 34:655-658. DOI: 10.1055/s-2002-38248
– reference: 17) Tanaka M, Takahashi S, Higashiura Y, et al.: Circulating level of fatty acid-binding protein 4 is an independent predictor of metabolic dysfunction-associated fatty liver disease in middle-aged and elderly individuals. Journal of diabetes investigation, 2021; 13: 878-888. DOI: 10.1111/jdi.13735
– reference: 4) Xu Y, Ma X, Pan X, He X, Wang Y, Bao Y.: Serum adipocyte fatty acid-binding protein levels: An indicator of non-alcoholic fatty liver disease in Chinese individuals. Liver Int, 2019; 39: 568-574. DOI: 10.1111/liv.14021
– reference: 1) Feng G, Valenti L, Wong VW, et al.: Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol, 2024; 21:46-56. DOI: 10.1038/s41575-023-00846-4
– reference: 2) Yki-Jarvinen H.: Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. The lancet Diabetes & endocrinology, 2014; 2:901-910. DOI: 10.1016/S2213-8587(14)70032-4
– reference: 19) Bedogni G, Bellentani S, Miglioli L, Morgan-Bathke M, Jensen MD.: The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol, 2006; 6:33. DOI: 10.1186/1471-230X-6-33
– reference: 11) Semnani-Azad Z, Connelly PW, Bazinet RP, et al.: Adipose tissue insulin resistance is longitudinally associated with adipose tissue dysfunction, circulating lipids, and dysglycemia: The PROMISE Cohort. Diabetes Care, 2021; 44:1682-1691. DOI: 10.2337/dc20-1918
– reference: 7) Pajvani UB, Du X, Combs TP, et al.: Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem, 2003; 278: 9073-9085. DOI: 10.1074/jbc.M207198200
– reference: 10) Hosooka T, Hosokawa Y, Matsugi K, et al.: The PDK1-FoxO1 signaling in adipocytes controls systemic insulin sensitivity through the 5-lipoxygenase-leukotriene B(4) axis. Proc Natl Acad Sci U S A, 2020; 117:11674-11684. DOI: 10.1073/pnas.1921015117
– reference: 12) Zhang K, Pan H, Wang L, Yang H, Zhu H, Gong F.: Adipose tissue insulin resistance is closely associated with metabolic syndrome in northern Chinese populations. Diabetes Metab Syndr Obes, 2021; 14:1117-1128. DOI: 10.2147/DMSO.S291350
– reference: 14) Chiriaco M, Nesti L, Flyvbjerg A, et al.: At any level of adiposity, relatively elevated leptin concentrations are associated with decreased insulin sensitivity. J Clin Endocrinol Metab, 2024; 109:461-470. DOI: 10.1210/clinem/dgad505
– reference: 3) Delarue J, Magnan C.: Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care, 2007; 10:142-148. DOI: 10.1097/MCO.0b013e328042ba90
– reference: 16) Lee JJ, Britton KA, Pedley A, et al.: Adipose tissue depots and their cross-sectional associations with circulating biomarkers of metabolic regulation. Journal of the American Heart Association, 2016: 5. DOI: 10.1161/JAHA.115.002936
– reference: 22) Hershkop K, Besor O, Santoro N, Pierpont B, Caprio S, Weiss R.: Adipose insulin resistance in obese adolescents across the spectrum of glucose tolerance. J Clin Endocrinol Metab, 2016; 101:2423-2431. DOI: 10.1210/jc.2016-1376
– reference: 18) Sondergaard E, Espinosa De Ycaza AE, Morgan-Bathke M, et al.: How to measure adipose tissue insulin sensitivity. J Clin Endocrinol Metab, 2017; 102:1193-1199. DOI: 10.1210/jc.2017-00047
– reference: 5) Gastaldelli A, Harrison SA, Belfort-Aguilar R, et al.: Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology, 2009; 50:1087-1093. DOI: 10.1002/hep.23116
– reference: 24) Wei Y, Liu J, Wang G, Wang Y.: Sex differences in the association between adipose insulin resistance and non-alcoholic fatty liver disease in Chinese adults. Biol Sex Differ, 2023; 14:69. DOI: 10.1186/s13293-023-00549-0
– reference: 6) Saladin R, De Vos P, Guerre-Millo M, et al.: Transient increase in obese gene expression after food intake or insulin administration. Nature, 1995; 377:527-529. DOI: 10.1038/377527a0
– reference: 20) Bosquet A, Guaita-Esteruelas S, et al.: Exogenous FABP4 induces endoplasmic reticulum stress in HepG2 liver cells. Atherosclerosis, 2016; 249:191-199. DOI: 10.1016/j.atherosclerosis.2016.04.012
– reference: 21) Francisco V, Sanz MJ, Real JT, et al.: Adipokines in non-alcoholic fatty liver disease: Are we on the road toward new biomarkers and therapeutic targets? Biology(Basel), 2022: 11. DOI: 10.3390/biology11081237
– reference: 15) Fischer J, Volzke H, Kassubek J, et al.: Associations of a panel of adipokines with fat deposits and metabolic phenotypes in a general population. Obesity, 2020; 28:1550-1559. DOI: 10.1002/oby.22871
– reference: 25) Li X, Liu J, Zhou B, et al.: Sex differences in the effect of testosterone on adipose tissue insulin resistance from overweight to obese adults. J Clin Endocrinol Metab, 2021; 106:2252-2263. DOI: 10.1210/clinem/dgab325
– reference: 13) Adams-Huet B, Devaraj S, Siegel D, Siegel D, Jialal I.: Increased adipose tissue insulin resistance in metabolic syndrome: relationship to circulating adipokines. Metab Syndr Relat Disord, 2014; 12:503-507. DOI: 10.1089/met.2014.0092
SSID ssib006761116
ssib052071327
ssj0003321989
Score 2.0027642
SourceID jstage
SourceType Publisher
StartPage 1
SubjectTerms fatty acid binding protein 4
fatty liver index
leptin
Title 成人における脂肪組織インスリン抵抗性およびアディポカインと肝臓の脂肪蓄積との関連 ―横断研究
URI https://www.jstage.jst.go.jp/article/jshp/27/1/27_20240724_1/_article/-char/ja
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 健康支援, 2025, Vol.27(1), pp.1-9
journalDatabaseRights – providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2758-3449
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib052071327
  issn: 1345-0174
  databaseCode: M~E
  dateStart: 20220101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NaxNBFF9KvXgRRcVvenBOkprd2Z2Pi7CbbCgePLXQ25LNbpAcqmh78SDNptBSEZTWeipIK9gP9CIV2j_HlST9L3xvZjZJpUKrUJbHmze_eR-7nXnDm4ll3ZcpbQrHTUsS5oeSK5hXqvMUq6xEg3vcSbymqrZ4wqZm3Mez3uzYeGekamlhPp5svDr1XMm_RBV4EFc8JXuOyA5AgQE0xBeeEGF4ninGJGRECCLLJHRJ4ONfSGFtSPzAEKLgSFsRDhHQJIhwkUbCIT7IcBJ4yERCEukaYV8TlATUcKBVc3x_pInhQICgCckVUSY-P6mGg9pqzgDQdwyO4AWHGo6sFpzgL_qApcJYgcICQeSgKTzNUoEC2lJfElEdwRn0Ag8wpZhUVtAHRUmIshBEEYgpoaoCKiuXKcSAja73SegpUA8JjJByDQj7NeWjGgkGp4-USEUN4hFZIUEZ33-F4KoRTYxH5QVgeDgyQBbyUvm3gs0-dhzKg4xQKgN-qPxcIKiOHEeVNWNjIIcdGQkcAwmjBKGWH7x8YJEsDDE7SPqcufraVTtXPmA4gl85i1eU-lXiM6U26OWPzJ_UxVpQ_cNLk6niOZCSlqirb6YtJl19IcSJfy56BrVHlmLytDnegzUvHlxpvXyK982qG_7cyB6uZwZVpua7jFAycnhk42PYIyra8Xxj1IIk64KDm3pY__s6HE5KwLOHOZTn4L6OuToXl3uUOlh3qDZ2jPG6HEIp-vAPNWGh24K0rygZVavY6cvWJZN-TvhapyvWWKt-1Vrprrz7dXSUt_fz9mrefp9nb_pLWT_b6x0s9Q7X8-xz3vmeZ4d5Zw-I7upBd_Vjd_ELCmcreRuatvLOcp5t553NPNs38u2dfrbZX17L2980Wn9tqbf7FvjAOd7YOl7cnvi5-KG7s9fd-Nr7tN7b_XHNmqmF05WpkvmFllLLoUyWbG43RKNMRT1ObC91JON2E1IQUXchMyjHTch3Et6ArK7eFHXmuDDjc0q5R-ssZnZCr1vjc8_m0hvWhO3FgjUb5XqCF2rFXMZJImO3Ccl_mtCkcdN6pB0XPdfX8ETnDO-t_wW4bV3Er0fvv96xxudfLKR3ISOZj--pN-Y3NVYGrQ
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%88%90%E4%BA%BA%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E8%84%82%E8%82%AA%E7%B5%84%E7%B9%94%E3%82%A4%E3%83%B3%E3%82%B9%E3%83%AA%E3%83%B3%E6%8A%B5%E6%8A%97%E6%80%A7%E3%81%8A%E3%82%88%E3%81%B3%E3%82%A2%E3%83%87%E3%82%A3%E3%83%9D%E3%82%AB%E3%82%A4%E3%83%B3%E3%81%A8%E8%82%9D%E8%87%93%E3%81%AE%E8%84%82%E8%82%AA%E8%93%84%E7%A9%8D%E3%81%A8%E3%81%AE%E9%96%A2%E9%80%A3+%E2%80%95%E6%A8%AA%E6%96%AD%E7%A0%94%E7%A9%B6&rft.jtitle=%E5%81%A5%E5%BA%B7%E6%94%AF%E6%8F%B4&rft.au=%E5%BC%95%E5%9C%B0%2C+%E5%84%AA%E4%BA%BA&rft.au=%E5%86%85%E7%94%B0%2C+%E9%81%BC%E5%A4%AA&rft.au=%E4%B8%AD%E5%9E%A3%E5%86%85%2C+%E7%9C%9F%E6%A8%B9&rft.au=%E6%B2%BC%E5%B0%BE%2C+%E6%88%90%E6%99%B4&rft.date=2025&rft.pub=%E6%97%A5%E6%9C%AC%E5%81%A5%E5%BA%B7%E6%94%AF%E6%8F%B4%E5%AD%A6%E4%BC%9A&rft.issn=1345-0174&rft.eissn=2758-3449&rft.volume=27&rft.issue=1&rft.spage=1&rft.epage=9&rft_id=info:doi/10.57438%2Fjshp.20240724_1&rft.externalDocID=article_jshp_27_1_27_20240724_1_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1345-0174&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1345-0174&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1345-0174&client=summon